Sutton Wealth Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-100
Closed -$3.17K 1273
2020
Q1
$3.17K Hold
100
﹤0.01% 956
2019
Q4
$4.23K Hold
100
﹤0.01% 967
2019
Q3
$3.16K Hold
100
﹤0.01% 1005
2019
Q2
$3.61K Hold
100
﹤0.01% 973
2019
Q1
$3.62K Buy
+100
New +$3.34K ﹤0.01% 976

Other funds holding SBIO

Sutton Wealth Advisors's SBIO Position: Q2 2020 in Review

Sutton Wealth Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2020, closing a stake of 100 shares — an estimated $3.17K sold.

Sutton Wealth Advisors first reported a position in SBIO in Q1 2019 and held it in 5 quarters. The position peaked at $4.23K in Q4 2019. 53 funds tracked by Wall St. Rank hold SBIO as of Q2 2020.

  • Sutton Wealth Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2020 after selling out during the quarter.
  • Sutton Wealth Advisors sold 100 ALPS Medical Breakthroughs ETF shares in Q2 2020, an estimated $3.17K.
  • Sutton Wealth Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q1 2019 and held it in 5 quarters.
  • Sutton Wealth Advisors's ALPS Medical Breakthroughs ETF position peaked at $4.23K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2020.

Based on Sutton Wealth Advisors's 13F filing for Q2 2020, filed 7 Nov 2023.